Reduction of Postoperative Pain After Milligan-Morgan Haemorrhoidectomy With Application of Vitamin E Ointment
NCT ID: NCT02554123
Last Updated: 2015-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
60 participants
INTERVENTIONAL
2015-01-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Experimental group (EG): Patients undergoing Milligan Morgan´s procedure and application of Vitamin E ointment on the surgical bed.
* Control group (CG): Patients undergoing Milligan Morgan´s procedure and application of Vaseline on the surgical bed.
Postoperative pain determined by VAS at the 1st, 3rd and 7th postoperative days, and need for morphine rescue will be investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical Analgesia Post-Haemorrhoidectomy
NCT04276298
Milligan-Morgan Versus Dearterialization With Mucopexy
NCT04863963
Topical Vitamin E Ovules for the Treatment of Hemorrhoids
NCT04362384
Reproducibility of Minimally Invasive Surgery for Grade III Hemorrhoids
NCT07171294
Implementation of Minimally Invasive Surgery for Grade III Hemorrhoids
NCT06851312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Experimental group (EG): Patients undergoing Milligan Morgan´s procedure and application of Vitamin E ointment on the surgical bed.
* Control group (CG): Patients undergoing Milligan Morgan´s procedure and application of Vaseline on the surgical bed.
Postoperative pain determined by VAS at the 1st, 3rd and 7th postoperative days, and need for morphine rescue will be investigated by a blined epidemiology nurse.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin E ointment
Vitamin E ointment application. Every 12 hours during 7 days.
Vitamin E ointment application
Vitamin E ointment application. Every 12 hours during 7 days.
Vaseline ointment
Vaseline ointment application. Every 12 hours during 7 days.
Vaseline ointment application
Vaseline ointment application. Every 12 hours during 7 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin E ointment application
Vitamin E ointment application. Every 12 hours during 7 days.
Vaseline ointment application
Vaseline ointment application. Every 12 hours during 7 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Haemorrhoids grade III and IV
* The patients sign an Informed Consent Form agreeing their participation in the study.
Exclusion Criteria
* Haemorrhoids grade I and II
* Patients with medical or surgical pathologies that do not allow the participation in the study
* Disability to understand and accept the entry in the study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General Universitario Elche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaime Ruiz-Tovar, MD, PhD
Professor of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Duran, MD, PhD
Role: STUDY_DIRECTOR
Hospital Rey Juan Carlos
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRJC15-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.